Corporate ManufacturerCached Profile
BOEHRINGER INGELHEIM PHARMACEUTICALS
Manufacturer Corporate ID: 100000000234
Subsidiaries Logged: 1 entities
LIFETIME CORPORATE SPEND
$2,936,085
General Payments Aggregated (2021–2025)
Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
Top Funded Physicians
Physicians receiving the highest promotional payments from this corporation.
1. Dr. ARTHUR LEEMedical Doctor
$90,0852. Dr. AYODEJI ADEGUNSOYEMedical Doctor
$89,8063. Dr. ADAM ROSENBLUTHMedical Doctor
$83,9854. Dr. BENJAMIN KALSMITHMedical Doctor
$64,4895. Dr. ANDREW FREEMANMedical Doctor
$64,335Top Promoted Products
Drugs or medical devices receiving the highest marketing backing.
1. JARDIANCE$1,803,171 (61.4%)
2. OFEV$317,768 (10.8%)
3. SPEVIGO$175,214 (6.0%)
4. STIOLTO RESPIMAT$15,557 (0.5%)
5. SPIRIVA$1,545 (0.1%)
Active Subsidiary Entities
Corporate subsidiaries and brands associated with this manufacturer ID in Open Payments.
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Corporate General Payouts Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2025
2025
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for BOEHRINGER INGELHEIM PHARMACEUTICALS...